Rebalix
iShares · sheet of 20 October 2026
iShares · sheet of 20 October 2026ETF sheet · official issuer and register data
iShares J.P. Morgan EM Local Govt Bond UCITS ETF
EMGA · IE00BFZPF546 · USD · domicile Ireland
Bonds · Government · Broad (all maturities) · Emerging markets
Index tracked: J.P. Morgan GBI-EM Global Diversified Capped Net Index
- TER
- 0.50%+ trans. 0.04%
- Fund size
- 491 m EUR
- Tracking difference
- −0.42%3-year avg
- 🇮🇹 tax rate
- 13.57%white list 92.05%
- Replication
- Physical (optimised)
- Income
- Accumulating
- Duration
- 5.18 yrsmedium (3–7 years)
Launch 31 May 2018 · costs from the KID as of 2 Oct 2026 · 353 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Oct 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the J.P. Morgan GBI-EM Global Diversified Capped Net Index, the Fund’s benchmark index (Index). The Share Class, via the Fund is passively managed, and aims to invest so far as possible and practicable in the fixed income (FI) securities (such as bonds) that make up the Index. These may include securities with a relatively low credit rating or which are unrated.…
Performance since series start (in euro) — base 100
29 May 2018 → 16 Oct 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +7.0% |
| 3 years | +18.1% |
| 5 years | +14.3% |
| 10 years | series too young |
| Since series start | +16.3% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 7.02% | 6.76% | 7.90% |
| Max drawdown | −6.01% | −8.38% | −22.00% |
| Sharpe | 0.18 | 0.71 | -0.01 |
| Sortino | 0.26 | 1.08 | -0.01 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · EMGA · IE00BFZPF5461
RebalixEMGA · IE00BFZPF546 · sheet of 20 October 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +18.43% | +18.80% | −0.38% |
| 2024 | −3.11% | −2.77% | −0.35% |
| 2023 | +12.07% | +12.60% | −0.52% |
| 2022 | −11.15% | −10.57% | −0.59% |
| 2021 | −10.35% | −9.74% | −0.62% |
Fixed income — as declared by the issuer
Issuer page · 15 Oct 2026 · investment-grade share (BBB−/Baa3 and above): 77.6%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Holdings
Portfolio as declared by the issuer · 30 Sept 2026 · 353 securities · top-10 weight = 13.1%
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
QDV7 · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse München / gettex, Tradegate Exchange, Xetra (Deutsche Börse)
EMGA · Euronext Amsterdam, Euronext Paris, London Stock Exchange
+ 5 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BFZPF546
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BFZPF546
Series, distributions, holdings and documents refresh daily.
Sheet produced on 20 October 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · EMGA · IE00BFZPF5462